State Street Corp Updates Passive Stake in Cogent Biosciences
Ticker: COGT · Form: SC 13G/A · Filed: Jan 23, 2024 · CIK: 1622229
| Field | Detail |
|---|---|
| Company | Cogent Biosciences, INC. (COGT) |
| Form Type | SC 13G/A |
| Filed Date | Jan 23, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**State Street Corp still owns Cogent Bio stock, no big changes here.**
AI Summary
State Street Corp, a major financial institution, filed an amended SC 13G/A on January 23, 2024, indicating its ownership of Cogent Biosciences, Inc. common stock as of December 31, 2023. This filing is an update to their previous disclosure, confirming their continued passive investment in Cogent Biosciences. For investors, this means a large institutional holder maintains its position, which can signal stability but doesn't suggest any immediate strategic changes for Cogent Biosciences.
Why It Matters
This filing confirms a significant institutional investor, State Street Corp, continues to hold shares in Cogent Biosciences, which can provide a level of confidence to other investors.
Risk Assessment
Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any new significant risks or opportunities.
Analyst Insight
Investors should note that a major institutional investor, State Street Corp, continues to hold a position in Cogent Biosciences, suggesting ongoing institutional interest, but this filing alone doesn't signal any new catalysts or concerns.
Key Players & Entities
- State Street Corp (company) — the reporting person filing the SC 13G/A
- Cogent Biosciences, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 23, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, indicating a change or update to a previously reported beneficial ownership of securities.
Who is the reporting entity in this filing?
The reporting entity is STATE STREET CORP, a financial institution based in Boston, MA.
Which company's stock is the subject of this filing?
The subject company is Cogent Biosciences, Inc., a pharmaceutical preparations company located in Waltham, MA.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023.
What is the CUSIP number for the securities mentioned?
The CUSIP number for the common stock of Cogent Biosciences, Inc. is 19240Q201.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 23, 2024 regarding Cogent Biosciences, Inc. (COGT).